StockData
Inogen Inc logo

Inogen Inc (INGN) stock

INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3069% below fair value
$5.30−0.12 (-2.21%)

Close on Nov 20, 2026Market cap $140.65MP/E –Yield –

Inogen free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Inogen's free cash flow for the twelve months ending Jun 30, 2026 was -$4.98M. For fiscal 2025 it was -$13.74M, down 637.9% from the year before. The highest annual figure on record is $57.58M in fiscal 2017.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.74M-637.9%
FY2024Dec 31, 2024$2.55M–
FY2023Dec 31, 2023-$8.45M–
FY2022Dec 31, 2022-$40.87M-325.2%
FY2021Dec 31, 2021$18.15M-44.4%
FY2020Dec 31, 2020$32.63M-12.9%
FY2019Dec 31, 2019$37.45M-27.9%
FY2018Dec 31, 2018$51.93M-9.8%
FY2017Dec 31, 2017$57.58M+96.4%
FY2016Dec 31, 2016$29.32M-18.5%
FY2015Dec 31, 2015$35.95M+154.2%
FY2014Dec 31, 2014$14.15M+35.5%
FY2013Dec 31, 2013$10.44M+427.1%
FY2012Dec 31, 2012$1.98M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.24M-39.0%
Q1 FY2026Mar 31, 2026-$6.90M–
Q4 FY2025Dec 31, 2025-$1.92M–
Q3 FY2025Sep 30, 2025$1.60M-69.9%
Q2 FY2025Jun 30, 2025$3.67M-44.8%
Q1 FY2025Mar 31, 2025-$17.08M–
Q4 FY2024Dec 31, 2024-$3.35M–
Q3 FY2024Sep 30, 2024$5.32M+260.3%
Q2 FY2024Jun 30, 2024$6.64M+233.6%
Q1 FY2024Mar 31, 2024-$6.06M–
Q4 FY2023Dec 31, 2023-$4.54M–
Q3 FY2023Sep 30, 2023$1.48M–
Q2 FY2023Jun 30, 2023$1.99M-57.3%
Q1 FY2023Mar 31, 2023-$7.38M–
Q4 FY2022Dec 31, 2022-$16.05M-375.6%
Q3 FY2022Sep 30, 2022-$10.02M–
Q2 FY2022Jun 30, 2022$4.66M-69.3%
Q1 FY2022Mar 31, 2022-$19.46M-1548.2%
Q4 FY2021Dec 31, 2021$5.82M-61.6%
Q3 FY2021Sep 30, 2021-$4.21M-173.5%
Q2 FY2021Jun 30, 2021$15.19M+19.8%
Q1 FY2021Mar 31, 2021$1.34M–
Q4 FY2020Dec 31, 2020$15.17M+78.0%
Q3 FY2020Sep 30, 2020$5.72M-60.0%
Q2 FY2020Jun 30, 2020$12.68M-27.1%
Q1 FY2020Mar 31, 2020-$939.00K–
Q4 FY2019Dec 31, 2019$8.52M-26.1%
Q3 FY2019Sep 30, 2019$14.30M+22.4%
Q2 FY2019Jun 30, 2019$17.39M-6.3%
Q1 FY2019Mar 31, 2019-$2.76M-127.1%
Q4 FY2018Dec 31, 2018$11.53M-5.3%
Q3 FY2018Sep 30, 2018$11.68M-28.2%
Q2 FY2018Jun 30, 2018$18.56M+12.3%
Q1 FY2018Mar 31, 2018$10.17M-19.4%
Q4 FY2017Dec 31, 2017$12.18M+146.1%
Q3 FY2017Sep 30, 2017$16.26M+84.8%
Q2 FY2017Jun 30, 2017$16.52M–
Q1 FY2017Mar 31, 2017$12.62M–
Q4 FY2016Dec 31, 2016$4.95M–
Q3 FY2016Sep 30, 2016$8.80M–

More Inogen figures

See a number that looks wrong?